American Brain Tumor Association Calls for Full Funding of 21st Century Cures Act Following U.S. Senate Approval

Printer Friendly

December 7, 2016 - Chicago, Illinois

Following passage last week by the U.S. House of Representatives, the U.S. Senate today approved the bipartisan “21st Century Cures Act” and sent the measure to the President, who is expected to sign the bill into law.

The American Brain Tumor Association (ABTA), the first and only national patient advocacy organization committed to brain tumors, applauded the inclusion of new investments for cancer research, including $1.8 billion for the Vice President’s Cancer Moonshot Initiative. These new investments will be funded from a new trust fund, and Congress will have to appropriate funding on an annual basis for these initiatives.

“The ABTA appreciates the hard work that went into achieving this bipartisan bill,” said ABTA President and CEO Elizabeth Wilson. “We also have been advocating for including the full $300 million authorized this year for the Cancer Moonshot in the continuing resolution that Congress is poised to approve before the end of the week. Congress heard the message from the cancer community, and it appears that this funding has been included in the continuing resolution.”

Yesterday, the ABTA participated in a “Media Day of Action” organized by One Voice Against Cancer, which encouraged the cancer community to send messages through social media to key members of Congress to encourage them to include this funding in the continuing resolution.  A draft of the continuing resolution, released last night, includes $872 million for the Cancer Moonshot, BRAIN Initiative, the Precision Medicine Initiative, and other important programs authorized by 21st Century Cures.  Congress is expected to clear the measure before the end of the week.

“This vital funding will soon be sent to the National Institutes of Health (NIH), allowing them to expeditiously award grants into new treatments for brain and other cancers,” stated Wilson. “This is an important victory, and we are committed to remaining vigilant in advocating for this funding every year to ensure the delivery of desperately needed breakthroughs in brain cancer research.”

For more information, visit or call 800-886-ABTA (2282).

About the American Brain Tumor Association

Founded in 1973, the American Brain Tumor Association was the first and is the only national patient advocacy organization committed to funding brain tumor research and providing support and education programs for people of all tumor types and all ages.

#  #  #

Media Contact: 

Phung Tran
(773) 577-8792